Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Microencapsul ; 31(7): 674-84, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24963960

RESUMEN

AIM: To study the effect of poly(d,l-lactic-co-glycolic acid) (PLGA) microparticles (MPs) preparation techniques on particle physical characterization with special emphasis on burst drug release. METHODS: A basic drug clozapine was used in combination with acid-terminated PLGA. Two approaches for MP preparation were compared; the in situ forming microparticle (ISM) and the emulsion-solvent evaporation (ESE) methods using an experimental design. The MPs obtained were compared according to their physical characterization, burst release and T80%. An in vivo pharmacokinetic study with in vitro-in vivo correlation (IVIVC) was also performed for the selected formula. RESULTS: Both methods were able to sustain drug release for three weeks. ISM produced more porous particles and was not effective as ESE for controlling burst release. A good IVIVC (R(2) = 0.9755) was attained when injecting the selected formula into rats. CONCLUSION: MPs prepared with ESE showed a minimum burst release and a level A IVIVC was obtained when administered to rats.


Asunto(s)
Antipsicóticos , Clozapina , Ácido Láctico , Ácido Poliglicólico , Animales , Antipsicóticos/química , Antipsicóticos/farmacocinética , Antipsicóticos/farmacología , Clozapina/química , Clozapina/farmacocinética , Clozapina/farmacología , Preparaciones de Acción Retardada , Ácido Láctico/química , Ácido Láctico/farmacocinética , Ácido Láctico/farmacología , Masculino , Ácido Poliglicólico/química , Ácido Poliglicólico/farmacocinética , Ácido Poliglicólico/farmacología , Copolímero de Ácido Poliláctico-Ácido Poliglicólico , Ratas
2.
Carbohydr Polym ; 94(1): 669-76, 2013 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-23544589

RESUMEN

Engineering polymer surfaces reduces nanoparticles (NPs) aggregation and phagocytosis due to effective shielding, hindering recognition by the reticuloendothelial system (RES). The shielding of NPs is complex and affected by the type of groups used in terms of charge and hydrophilicity. This will, in turn, affect NPs biodistribution which will determine the length of activity of the drug. Polysaccharides are nowadays recognized for decreasing the uptake of particulate carriers by the mononuclear phagocytic system (MPS). Chitosan is considered as an attractive candidate due to its biocompatibility, biodegradability, non-toxicity and low cost. In this study clozapine (CZP)-loaded NPs were coated with chitosan, pluronic F-68, polyethylene glycol (PEG) 4000 and polysorbate 80. The factors affecting drug encapsulation efficiency, particle size, surface charge, surface hydrophilicity, pharmacokinetics and biodistribution were studied. The results proved that although a similarity in surface hydrophilicity, chitosan-stealth NPs showed different pharmacokinetic profile and biodistribution behavior compared to polysorbate-stealth NPs.


Asunto(s)
Antipsicóticos/farmacocinética , Quitosano/química , Clozapina/farmacocinética , Nanocápsulas/química , Adsorción , Animales , Antipsicóticos/administración & dosificación , Antipsicóticos/química , Análisis Químico de la Sangre/normas , Clozapina/administración & dosificación , Clozapina/química , Composición de Medicamentos , Interacciones Hidrofóbicas e Hidrofílicas , Masculino , Ratones , Tamaño de la Partícula , Poloxámero/química , Polietilenglicoles/química , Polisorbatos/química , Ratas , Estándares de Referencia , Esterilización , Propiedades de Superficie , Distribución Tisular
3.
AAPS PharmSciTech ; 9(4): 1230-9, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-19089643

RESUMEN

Polysaccharides, which have been explored to possess gelling properties and a wide margin of safety, were used to formulate single-unit floating matrix tablets by a direct compression technique. This work has the aim to allow continuous slow release of famotidine above its site of absorption. The floating approach was achieved by the use of the low density polypropylene foam powder. Polysaccharides (kappa-carrageenan, gellan gum, xyloglucan, and pectin) and blends of polysaccharides (kappa-carrageenan and gellan gum) and cellulose ethers (hydroxypropylmethyl cellulose, hydroxypropylcellulose, sodium carboxymethyl cellulose) were tried to modulate the release characteristics. The prepared floating tablets were evaluated for their floating behavior, matrix integrity, swelling studies, in vitro drug release studies, and kinetic analysis of the release data. The differential scanning calorimetry and Fourier transform infrared spectroscopy studies revealed that changing the polymer matrix system by formulation of polymers blends resulted in formation of molecular interactions which may have implications on drug release characteristics. This was obvious from the retardation in drug release and change in its mechanistics.


Asunto(s)
Famotidina/farmacocinética , Polisacáridos/química , Comprimidos , Rastreo Diferencial de Calorimetría , Química Farmacéutica , Preparaciones de Acción Retardada , Famotidina/química , Espectroscopía Infrarroja por Transformada de Fourier
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA